Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
-
Publication Venue For
-
Average Weighted Accuracy (AWA): Pragmatic Analysis for a RADICAL Study.
2019
-
The Emperor's New Clothes: Prospective Observational Evaluation of the Association between Initial Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE).
2019
-
Confusion, Headache, and Constitutional Symptoms in a Heart Transplant Recipient..
68:1968-1973.
2019
-
Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV..
68:1823-1830.
2019
-
Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS)..
68:1961-1967.
2019
-
A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection..
68:1502-1511.
2019
-
Aminoglycoside-Induced Hearing Loss Among Patients Being Treated for Drug-Resistant Tuberculosis in South Africa: A Prediction Model.
2019
-
Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening of Patient-Reported Outcomes.
2019
-
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.
2019
-
Using data to optimize blood bottle fill volumes and pathogen detection - making blood cultures great again.
2019
-
Bioaerosol Sampling to Detect Avian Influenza Virus in Hanoi's Largest Live Poultry Market..
68:972-975.
2019
-
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa..
68:e1-e47.
2019
-
Invasive Fungal Infection after Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis.
2019
-
Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults..
68:865-872.
2019
-
How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers..
68:850-853.
2019
-
Glycocalyx Breakdown is Associated with Severe Disease and Fatal Outcome in Plasmodium falciparum Malaria.
2019
-
Depressive Symptoms and Engagement in Human Immunodeficiency Virus Care Following Antiretroviral Therapy Initiation..
68:475-481.
2019
-
A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation..
68:196-203.
2019
-
Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy..
68:273-279.
2019
-
Disparities and Determinants of Cancer Treatment in Elderly Americans Living With Human Immunodeficiency Virus/AIDS..
67:1904-1911.
2018
-
China-United States Research Collaborations in Antimicrobial Resistance..
67:S142-S145.
2018
-
Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients..
67:1720-1728.
2018
-
Best Care for Patients Achieved Through Multidisciplinary Stewardship..
67:1637.
2018
-
Cumulative Burden of Depression and All-Cause Mortality in Women Living With Human Immunodeficiency Virus..
67:1575-1581.
2018
-
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection..
67:1477-1492.
2018
-
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection.
2018
-
Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care Setting..
67:1168-1174.
2018
-
Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013..
67:327-333.
2018
-
Association of CYP2B6 Single-Nucleotide Polymorphisms Altering Efavirenz Metabolism With Hepatitis C Virus (HCV) Treatment Relapse Among Human Immunodeficiency Virus/HCV-Coinfected African Americans Receiving Ledipasvir/Sofosbuvir in the ION-4 Trial..
66:1953-1956.
2018
-
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1..
66:1222-1229.
2018
-
Adaptive Designs for Clinical Trials: Application to Healthcare Epidemiology Research..
66:1140-1146.
2018
-
Management of an Outbreak of Exophiala dermatitidis Bloodstream Infections at an Outpatient Oncology Clinic..
66:959-962.
2018
-
Evidence for Cross-species Influenza A Virus Transmission Within Swine Farms, China: A One Health, Prospective Cohort Study..
66:533-540.
2018
-
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae..
66:163-171.
2018
-
Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical Trial..
66:72-80.
2018
-
IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C..
65:1773-1775.
2017
-
Screening Veterans for Syphilis: Implementation of the Reverse Sequence Algorithm..
65:1930-1933.
2017
-
African Tick Bite Fever Treated Successfully With Rifampin in a Patient With Doxycycline Intolerance..
65:1582-1584.
2017
-
Electronically Available Comorbidities Should Be Used in Surgical Site Infection Risk Adjustment..
65:803-810.
2017
-
Implementation of Antimicrobial Stewardship Programs in Small Community Hospitals: Recognizing the Barriers and Meeting the Challenge..
65:697-698.
2017
-
Procalcitonin: The Right Answer but to Which Question?.
65:191-193.
2017
-
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study..
65:6-12.
2017
-
Real-World Effectiveness of DAA Therapies in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection: 996 Veterans Can't Be Wrong..
64:1721-1723.
2017
-
Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis..
64:1619-1621.
2017
-
A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk..
64:1380-1386.
2017
-
Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease..
64:1074-1080.
2017
-
Two-Phase Hospital-Associated Outbreak of Mycobacterium abscessus: Investigation and Mitigation..
64:902-911.
2017
-
Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group..
64:S41-S47.
2017
-
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality..
64:711-718.
2017
-
Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group..
64:S30-S35.
2017
-
Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group..
64:S24-S29.
2017
-
The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress..
64:S3-S7.
2017
-
The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group..
64:S36-S40.
2017
-
Transforming Concepts Into Clinical Trials and Creating a Multisite Network: The Leadership and Operations Center of the Antibacterial Resistance Leadership Group..
64:S8-S12.
2017
-
Reply to Strahilevitz and Shapira..
64:534-535.
2017
-
Expert Consensus on Metrics to Assess the Impact of Patient-Level Antimicrobial Stewardship Interventions in Acute-Care Settings..
64:377-383.
2017
-
MASTERMIND: Bringing Microbial Diagnostics to the Clinic..
64:355-360.
2017
-
Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a Thing..
64:92-99.
2017
-
Are People Living Near Modern Swine Production Facilities at Increased Risk of Influenza Virus Infection?.
63:1558-1563.
2016
-
Reply to Strahilevitz and Shapira.
2016
-
Galactomannan, β-D-Glucan, and Polymerase Chain Reaction-Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis..
63:1340-1348.
2016
-
Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials..
63:1042-1048.
2016
-
Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial..
63:999-1006.
2016
-
Fluconazole Prophylaxis for the Prevention of Candidiasis in Premature Infants: A Meta-analysis Using Patient-level Data..
63:604-610.
2016
-
Efficient Delivery of Investigational Antibacterial Agents via Sustainable Clinical Trial Networks..
63 Suppl 2:S57-S59.
2016
-
Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America..
63:433-442.
2016
-
Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team..
63 Suppl 2:S29-S36.
2016
-
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America..
63:e1-e60.
2016
-
Reply to Lesho and Clifford..
63:571-572.
2016
-
Successful Re-treatment of Hepatitis C Virus in Patients Coinfected With HIV Who Relapsed After 12 Weeks of Ledipasvir/Sofosbuvir..
63:528-531.
2016
-
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses..
63:356-362.
2016
-
Statin Utilization and Recommendations Among HIV- and HCV-infected Veterans: A Cohort Study..
63:407-413.
2016
-
Hypertension Among HIV-infected Patients in Clinical Care, 1996-2013..
63:242-248.
2016
-
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials..
63:268-280.
2016
-
Editorial Commentary: Life-saving Antimicrobial Drugs: What Are We Doing to Pricing and Availability?.
62:1569-1570.
2016
-
Reply to Dr Fierer..
62:954.
2016
-
A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa..
62 Suppl 1:S42-S46.
2016
-
Reply to Phillips, Morris, and Walker..
62:815-816.
2016
-
The Relationship Between Invasive Nontyphoidal Salmonella Disease, Other Bacterial Bloodstream Infections, and Malaria in Sub-Saharan Africa..
62 Suppl 1:S23-S31.
2016
-
The Typhoid Fever Surveillance in Africa Program (TSAP): Clinical, Diagnostic, and Epidemiological Methodologies..
62 Suppl 1:S9-S16.
2016
-
Utilization of Healthcare in the Typhoid Fever Surveillance in Africa Program..
62 Suppl 1:S56-S68.
2016
-
Validation and Identification of Invasive Salmonella Serotypes in Sub-Saharan Africa by Multiplex Polymerase Chain Reaction..
62 Suppl 1:S80-S82.
2016
-
Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight..
62:323-333.
2016
-
Poliomyelitis in Pakistan..
62:199.
2016
-
Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II..
62:181-189.
2016
-
Potential Microbiological Effects of Higher Dosing of Echinocandins..
61 Suppl 6:S669-S677.
2015
-
Bloodstream Infections and Frequency of Pretreatment Associated With Age and Hospitalization Status in Sub-Saharan Africa..
61 Suppl 4:S372-S379.
2015
-
Poor Positive Predictive Value of Lyme Disease Serologic Testing in an Area of Low Disease Incidence..
61:1374-1380.
2015
-
RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration..
61Suppl 3:S155-S159.
2015
-
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults..
61:e26-e46.
2015
-
Executive Summary: 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults..
61:859-863.
2015
-
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality..
61 Suppl 2:S87-S93.
2015
-
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)..
61:800-806.
2015
-
Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study..
61:527-535.
2015
-
Reply to Solnick..
61:485-486.
2015
-
Unorthodox alternative therapies marketed to treat Lyme disease..
60:1776-1782.
2015
-
Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230..
60:1552-1558.
2015
-
Point-of-prescription interventions to improve antimicrobial stewardship..
60:1252-1258.
2015
-
Reply to DiNubile..
60:1291-1292.
2015
-
Delay in diagnosis of invasive surgical site infections following knee arthroplasty versus hip arthroplasty..
60:990-996.
2015
-
Long-term persistence of zoster vaccine efficacy..
60:900-909.
2015
-
Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study..
60:741-749.
2015
-
Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureus..
60:787-796.
2015
-
Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults..
60:627-638.
2015
-
Editorial commentary: NOVA score to predict endocarditis in patients with enterococcal bacteremia: sticking to valves or to scores?.
60:536-538.
2015
-
Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study..
60:254-262.
2015
-
Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression..
60:36-44.
2015
-
Maternal immunization: opportunities for scientific advancement..
59 Suppl 7:S408-S414.
2014
-
Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices..
59 Suppl 7:S400-S407.
2014
-
Editorial commentary: Fluconazole therapeutic drug monitoring in children with cancer: not today..
59:1534-1536.
2014
-
Invasive gram-positive bacterial infection in cancer patients..
59 Suppl 5:S331-S334.
2014
-
Update on epidemiology of and preventive strategies for invasive fungal infections in cancer patients..
59 Suppl 5:S352-S355.
2014
-
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America..
59:e96-138.
2014
-
Antimicrobial stewardship: philosophy versus practice..
59 Suppl 3:S112-S121.
2014
-
New "One Health" strategies needed for detection and control of emerging pathogens at Cantonese live animal markets, China..
59:1194-1197.
2014
-
Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines..
59:962-968.
2014
-
Editorial commentary: zoster vaccine in immunocompromised patients: time to reconsider current recommendations..
59:920-922.
2014
-
Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections..
59:798-807.
2014
-
Drug susceptibility and resistance mutations after first-line failure in resource limited settings..
59:706-715.
2014
-
First evidence of H10N8 Avian influenza virus infections among feral dogs in live poultry markets in Guangdong province, China..
59:748-750.
2014
-
Very low levels of 25-hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated cryptococcal meningitis..
59:493-500.
2014
-
Antibacterial resistance leadership group: open for business..
58:1571-1576.
2014
-
Virological and epidemiological evidence of avian influenza virus infections among feral dogs in live poultry markets, china: a threat to human health?.
58:1644-1646.
2014
-
Infections during peginterferon/ribavirin therapy are associated with the magnitude of decline in absolute lymphocyte count: results of the IDEAL study..
58:960-969.
2014
-
A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease..
58:663-671.
2014
-
Invasive Salmonella infections in areas of high and low malaria transmission intensity in Tanzania..
58:638-647.
2014
-
Methicillin-resistant Staphylococcus aureus: an evolving pathogen..
58 Suppl 1:S10-S19.
2014
-
Better tests, better care: improved diagnostics for infectious diseases..
57 Suppl 3:S139-S170.
2013
-
Editorial commentary: variant Influenza A(H3N2) virus: looking through a glass, darkly..
57:1713-1714.
2013
-
Reply to Parra-Ruiz..
57:1219-1220.
2013
-
Editorial commentary: "excess readmissions" for pneumonia: a dilemma with a penalty..
57:368-369.
2013
-
10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America..
56:1685-1694.
2013
-
Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations..
56:1724-1732.
2013
-
Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections?.
56:1779-1788.
2013
-
Reply to Tleyjeh and Baddour..
56:1845.
2013
-
Environmental predictors and incubation period of AIDS-associated penicillium marneffei infection in Ho Chi Minh City, Vietnam..
56:1273-1279.
2013
-
Editorial commentary: telephone consultation for Staphylococcus aureus bacteremia: opening Pandora's box..
56:536-538.
2013
-
Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke..
56:209-217.
2013
-
Reply to Seddon, Schaaf, and Hesseling..
56:168-169.
2013
-
Transmission of hepatitis B virus from an orthopedic surgeon with a high viral load..
56:218-224.
2013
-
Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections..
55:1495-1502.
2012
-
Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy..
55:1320-1328.
2012
-
Does nonpayment for hospital-acquired catheter-associated urinary tract infections lead to overtesting and increased antimicrobial prescribing?.
55:923-929.
2012
-
White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens..
55:1031-1046.
2012
-
Ceftaroline applications for therapy in the United States..
55 Suppl 3:S171-S172.
2012
-
Fool's gold: Why imperfect reference tests are undermining the evaluation of novel diagnostics: a reevaluation of 5 diagnostic tests for leptospirosis..
55:322-331.
2012
-
Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B..
55:461-468.
2012
-
Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis..
55:572-581.
2012
-
Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study..
55:42-50.
2012
-
Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study..
55:242-250.
2012
-
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years..
54:922-928.
2012
-
Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study..
54:502-510.
2012
-
Outcomes following candiduria in extremely low birth weight infants..
54:331-339.
2012
-
Evidence for subclinical avian influenza virus infections among rural Thai villagers..
53:e107-e116.
2011
-
Pedicure-associated rapidly growing mycobacterial infection: an endemic disease..
53:787-792.
2011
-
Antimicrobial stewardship programs in community hospitals: the evidence base and case studies..
53 Suppl 1:S23-S28.
2011
-
Q fever, spotted fever group, and typhus group rickettsioses among hospitalized febrile patients in northern Tanzania..
53:e8-15.
2011
-
Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia..
53:1-9.
2011
-
A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections..
52 Suppl 7:S520-S526.
2011
-
Case report: treatment of chronic osteomyelitis..
52 Suppl 7:S538-S541.
2011
-
Introduction: fusidic acid enters the United States..
52 Suppl 7:S467-S468.
2011
-
New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the good..
52 Suppl 7:S469-S476.
2011
-
Combating antimicrobial resistance: policy recommendations to save lives..
52 Suppl 5:S397-S428.
2011
-
Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam..
52:945-952.
2011
-
Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania..
52:341-348.
2011
-
Editorial commentary: the problem with pigs: it's not about bacon..
52:19-22.
2011
-
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens..
52:31-40.
2011
-
AIDS-associated Penicillium marneffei infection of the central nervous system..
51:1458-1462.
2010
-
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV..
51:1209-1216.
2010
-
AIDS‐associated Cryptococcus neoformans and Penicillium marneffei coinfection: a therapeutic dilemma in resource‐limited settings..
51:e65-e68.
2010
-
Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients..
51:1062-1069.
2010
-
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection..
51:641-650.
2010
-
Final report of the Lyme disease review panel of the Infectious Diseases Society of America..
51:1-5.
2010
-
Factors associated with mortality in transplant patients with invasive aspergillosis..
50:1559-1567.
2010
-
Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases..
50:e63-e68.
2010
-
Synergistic pandemics: confronting the global HIV and tuberculosis epidemics..
50 Suppl 3:S67-S70.
2010
-
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)..
50:1101-1111.
2010
-
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database..
50:1091-1100.
2010
-
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america..
50:291-322.
2010
-
Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007)..
50 Suppl 1:S26-S33.
2010
-
Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021..
50:106-114.
2010
-
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis..
49:1721-1728.
2009
-
Treatment and CD4+ T cell count recovery among antiretroviral therapy-naive patients with HIV/AIDS..
49:1619-1620.
2009
-
Postoperative joint infections due to Propionibacterium species: a case-control study..
49:1083-1085.
2009
-
Invasive non-Typhi Salmonella disease in Africa..
49:606-611.
2009
-
Legionella as a cause of hyperpyrexia..
49:646-647.
2009
-
A balancing act: microbe versus muscle..
49:181-183.
2009
-
Emergence of extended-spectrum beta-lactamase-producing Escherichia coli in community hospitals throughout North Carolina: a harbinger of a wider problem in the United States?.
49:e30-e32.
2009
-
Invasive aspergillosis due to Neosartorya udagawae..
49:102-111.
2009
-
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry..
48:1695-1703.
2009
-
Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus..
48 Suppl 4:S260-S270.
2009
-
Staphylococcus aureus bloodstream infections: definitions and treatment..
48 Suppl 4:S254-S259.
2009
-
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic..
48:713-721.
2009
-
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America..
48:503-535.
2009
-
Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?.
48:580-586.
2009
-
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry..
48:265-273.
2009
-
Kidney disease in patients with HIV infection and AIDS..
47:1449-1457.
2008
-
Cryptococcosis in solid organ transplant recipients: current state of the science..
47:1321-1327.
2008
-
Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit..
47 Suppl 2:S55-S99.
2008
-
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria..
47:674-683.
2008
-
Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions..
47:542-553.
2008
-
A 41-year-old woman from Cameroon with infertility..
47:141-109.
2008
-
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group..
46:1813-1821.
2008
-
Epidemiology of methicillin-resistant Staphylococcus aureus..
46 Suppl 5:S344-S349.
2008
-
Management of methicillin-resistant Staphylococcus aureus bacteremia..
46 Suppl 5:S386-S393.
2008
-
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms..
46:1683-1693.
2008
-
The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals..
46:1568-1577.
2008
-
Aerosolized antifungal prophylaxis: the winds of change?.
46:1409-1411.
2008
-
When primary antifungal therapy fails..
46:1426-1433.
2008
-
A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003-2004..
46 Suppl 3:S271-S293.
2008
-
Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board..
46 Suppl 3:S258-S270.
2008
-
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America..
46:327-360.
2008
-
Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis..
46:232-242.
2008
-
Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen..
46:e12-e18.
2008
-
Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact..
46:120-128.
2008
-
HIV's challenge to measles control..
45:1425-1426.
2007
-
Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania..
45:1492-1498.
2007
-
A 6-year-old boy with facial swelling and monocular blindness..
45:1207-1239.
2007
-
Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006..
45:1120-1131.
2007
-
Immune reconstitution syndrome and exacerbation of infections after pregnancy..
45:1192-1199.
2007
-
Extensively drug-resistant tuberculosis: are we learning from history or repeating it?.
45:338-342.
2007
-
Infection due to 3 avian influenza subtypes in United States veterinarians..
45:4-9.
2007
-
Cases of swine influenza in humans: a review of the literature..
44:1084-1088.
2007
-
Combination therapy for malaria: mission accomplished?.
44:1075-1077.
2007
-
Pharmacokinetics of rifampicin..
44:618-619.
2007
-
Early surgery in patients with infective endocarditis: a propensity score analysis..
44:364-372.
2007
-
Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts..
44:402-409.
2007
-
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia..
44:190-196.
2007
-
Recommendations for the management of herpes zoster..
44 Suppl 1:S1-26.
2007
-
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial..
44:2-12.
2007
-
Telithromycin and myasthenic crisis..
43:1621-1622.
2006
-
Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt..
43:1031-1039.
2006
-
Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration..
43:783-786.
2006
-
Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002..
43:49-54.
2006
-
Fever in patients with mixed-species malaria..
42:1713-1718.
2006
-
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections..
42:1726-1734.
2006
-
Acute hearing loss and rickettsial diseases..
42:1506.
2006
-
Clinical features of scrub typhus..
42:1505-1506.
2006
-
Methicillin-resistant Staphylococcus aureus bacteremia after isolation from urine..
42:1504-1505.
2006
-
Use of sentinel laboratories by clinicians to evaluate potential bioterrorism and emerging infections..
42:1311-1324.
2006
-
A large, multiple-restaurant outbreak of infection with Shigella flexneri serotype 2a traced to tomatoes..
42:163-169.
2006
-
Are swine workers in the United States at increased risk of infection with zoonotic influenza virus?.
42:14-20.
2006
-
A returning traveler with fever and rash..
41:1453-1530.
2005
-
Glucose homeostasis abnormalities associated with use of gatifloxacin..
41:1269-1276.
2005
-
Do not abandon amphotericin B as an antifungal bladder irrigant..
41:1073-1074.
2005
-
The proposed closing of the Armed Forces Institute of Pathology..
41:1003-1004.
2005
-
Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans..
41:654-659.
2005
-
Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database..
41:507-514.
2005
-
A man with chronic leg edema, purpuric skin lesions, and abdominal lymphadenopathy..
41.
2005
-
Repeat infective endocarditis: differentiating relapse from reinfection..
41:406-409.
2005
-
Symptomatic respiratory syncytial virus infection in previously healthy young adults living in a crowded military environment..
41:311-317.
2005
-
Community permission for medical research in developing countries..
41:255-259.
2005
-
An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients..
40:1756-1761.
2005
-
Classification of community-acquired endocarditis due to coagulase-negative staphylococci..
40:1704.
2005
-
Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria..
40:1601-1607.
2005
-
Is it time to abandon the use of amphotericin B bladder irrigation?.
40:1465-1470.
2005
-
Study of renal safety in amphotericin B lipid complex-treated patients..
40 Suppl 6:S414-S421.
2005
-
Successful use of amphotericin B lipid complex in the treatment of cryptococcosis..
40 Suppl 6:S409-S413.
2005
-
Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex..
40 Suppl 6:S401-S408.
2005
-
Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia..
40:695-703.
2005
-
Aortic coarctation endarteritis in an adult: case report with cardiovascular magnetic resonance imaging findings and review of the literature..
40:e28-e31.
2005
-
Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome..
40:89-99.
2005
-
Remarks concerning testing parameters for blood cultures..
40:202.
2005
-
Surgical site infection in the elderly population..
39:1835-1841.
2004
-
Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database..
39:1527-1530.
2004
-
Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients..
39 Suppl 4:S207-S210.
2004
-
Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment..
39:e70-e73.
2004
-
Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality..
39:517-525.
2004
-
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases..
39:192-198.
2004
-
Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus..
38:1555-1560.
2004
-
Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database..
38:1323-1327.
2004
-
Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia..
38:1243-1250.
2004
-
West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review..
38:1257-1260.
2004
-
Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin..
38:1188-1191.
2004
-
Two regimens of azithromycin prophylaxis against community-acquired respiratory and skin/soft-tissue infections among military trainees..
38:1095-1101.
2004
-
Active or prior GB virus C infection does not protect against vertical transmission of HIV in coinfected women from Tanzania..
38:e46-e48.
2004
-
An outbreak of foodborne botulism associated with food sold at a salvage store in Texas..
37:1490-1495.
2003
-
Two decades of disseminated tuberculosis at a university medical center: the expanding role of mycobacterial blood culture..
37:1037-1043.
2003
-
Advances against aspergillosis..
37 Suppl 3:S155-S156.
2003
-
Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001..
37 Suppl 3:S188-S224.
2003
-
Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis..
37 Suppl 3:S157-S187.
2003
-
Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi..
37:221-229.
2003
-
Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae..
37:75-81.
2003
-
Sexual transmission of typhoid fever: a multistate outbreak among men who have sex with men..
37:141-144.
2003
-
The health and economic burden of genital warts in a set of private health plans in the United States..
36:1397-1403.
2003
-
Voriconazole treatment for less-common, emerging, or refractory fungal infections..
36:1122-1131.
2003
-
The value of an infectious diseases specialist..
36:1013-1017.
2003
-
Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens..
36:858-862.
2003
-
Treatment and prevention of postherpetic neuralgia..
36:877-882.
2003
-
Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection..
36:592-598.
2003
-
Geographical differences in human oral yeast flora..
36:221-224.
2003
-
Advances against aspergillosis..
37 Suppl 3.
2003
-
Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients..
36:46-52.
2003
-
Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci..
35:1139-1146.
2002
-
Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention..
35:950-959.
2002
-
Bacterial contamination of animal feed and its relationship to human foodborne illness..
35:859-865.
2002
-
Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia..
35:896-897.
2002
-
National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000..
35:S126-S134.
2002
-
Reactivation of retinal toxoplasmosis despite evidence of immune response to highly active antiretroviral therapy..
35:e37-e39.
2002
-
Comparative analysis of commercial assays for the detection and quantification of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in plasma from patients infected with HIV-1 subtype C..
35:323-325.
2002
-
Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998..
34:1593-1599.
2002
-
Acute terminal ileitis associated with pneumococcal bacteremia: case report and review of pneumococcal gastrointestinal diseases..
34:E50-E53.
2002
-
Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1..
34:991-1001.
2002
-
Large epidemic of respiratory illness due to adenovirus types 7 and 3 in healthy young adults..
34:577-582.
2002
-
Postoperative bacteremia secondary to surgical site infection..
34:305-308.
2002
-
The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis..
33:1824-1833.
2001
-
Introduction.
30:165.
2000
-
Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol.
2017
-
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.
2017
-
GeneXpert MTB/Rif to Diagnose Tuberculous Meningitis: Perhaps the First Test but not the Last.
2016